24 May 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. This announcement is an advertisement and not an […]
https://www.belluscura.com/wp-content/uploads/2021/05/Untitled-design-39.png34566912Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2021-05-24 01:01:162021-05-24 01:01:16Belluscura plc (UK)…Confirmation of Issue Price for Placing on the AIM market of the London Stock Exchange
LONDON, U.K. AND PLANO, TX, U.S. (7 May 2021). Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces its intention to seek admission of the entire issued and to be issued ordinary share capital of the Company to the AIM market of the London Stock Exchange (“Admission“). […]
https://www.belluscura.com/wp-content/uploads/2021/05/Untitled-design-39.png34566912Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2021-05-07 01:00:012021-05-07 01:05:31Belluscura Intends to Float on AIM
Belluscura is excited to announce that the X-PLO2R™ portable oxygen concentrator has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). We are extremely proud to bring this technology to the market, in doing our part to help improve the quality of life for millions of people worldwide who suffer from chronic […]
Each year, Respiratory Therapists (RT) are celebrated during Respiratory Care Week, happening this year from October 25th to October 31st. RT’s play a vital role in the lives of various patient populations, and most notably this year, providing hands-on care for patients whose breathing has been compromised by the SARS-CoV-2 (COVID-19 Virus) pandemic. Ruthie Marker MSRC, RRT, Manager […]
Today, the U.S. Food and Drug Administration (FDA) issued this immediately in effect guidance: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease-2019 (COVID-19) Public Health Emergency. The FDA believes the policy set forth in this guidance may help address urgent public health concerns by helping to expand the availability […]
https://www.belluscura.com/wp-content/uploads/2020/03/200828-fda-editorial.jpg6831024Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2020-03-22 20:24:582020-10-07 20:03:49New FDA Guidance Provides a Policy Designed to Expand the Availability of Respiratory Devices, Including Oxygen Concentrators, During the COVID-19 Pandemic
LONDON, UK, PLANO, TX AND WAYNESBURG, PA, March 13, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel modular portable oxygen enrichment ventilation systems for treating patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS) brought […]
https://www.belluscura.com/wp-content/uploads/2020/10/shutterstock_1021251352-scaled.jpg13912560Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2020-03-14 01:25:052020-10-07 15:32:42Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation system
LONDON, UK AND PLANO, TX, February 6, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems for treating patients suffering from acute respiratory distress syndrome (ARDS). The latest patent application covers devices and […]
https://www.belluscura.com/wp-content/uploads/2020/02/0a1-11.jpg5621000Belluscurahttps://www.belluscura.com/wp-content/uploads/2020/09/Belluscura-Logo-cl-2.pngBelluscura2020-02-06 19:48:322020-10-07 15:34:00Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy
Admission Document
/in Belluscura News /by BelluscuraClick the link below to view the document. FINAL ADMISSION DOCUMENT (24 MAY 2021)
Belluscura plc (UK)…Confirmation of Issue Price for Placing on the AIM market of the London Stock Exchange
/in Belluscura News /by Belluscura24 May 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. This announcement is an advertisement and not an […]
Belluscura Intends to Float on AIM
/in Belluscura News /by BelluscuraLONDON, U.K. AND PLANO, TX, U.S. (7 May 2021). Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces its intention to seek admission of the entire issued and to be issued ordinary share capital of the Company to the AIM market of the London Stock Exchange (“Admission“). […]
X-PLO₂R™ Portable Oxygen Concentrator Receives FDA Clearance
/3 Comments/in Belluscura News /by BelluscuraBelluscura is excited to announce that the X-PLO2R™ portable oxygen concentrator has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). We are extremely proud to bring this technology to the market, in doing our part to help improve the quality of life for millions of people worldwide who suffer from chronic […]
Respiratory Therapist Spotlight: Ruthie Marker MSRC, RRT
/in Belluscura News /by BelluscuraEach year, Respiratory Therapists (RT) are celebrated during Respiratory Care Week, happening this year from October 25th to October 31st. RT’s play a vital role in the lives of various patient populations, and most notably this year, providing hands-on care for patients whose breathing has been compromised by the SARS-CoV-2 (COVID-19 Virus) pandemic. Ruthie Marker MSRC, RRT, Manager […]
New FDA Guidance Provides a Policy Designed to Expand the Availability of Respiratory Devices, Including Oxygen Concentrators, During the COVID-19 Pandemic
/in Belluscura News /by BelluscuraToday, the U.S. Food and Drug Administration (FDA) issued this immediately in effect guidance: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease-2019 (COVID-19) Public Health Emergency. The FDA believes the policy set forth in this guidance may help address urgent public health concerns by helping to expand the availability […]
Belluscura and its research partner, Separation Design Group, announce the filing of a patent application on a modular portable oxygen enrichment ventilation system
/in Belluscura News /by BelluscuraLONDON, UK, PLANO, TX AND WAYNESBURG, PA, March 13, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel modular portable oxygen enrichment ventilation systems for treating patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS) brought […]
Belluscura announces filing of a patent application on an oxygen enrichment device and system for treating acute respiratory distress (ARDS), including ARDS caused by the recent Coronavirus
/in Belluscura News /by BelluscuraLONDON, UK AND PLANO, TX, February 6, 2020. Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems for treating patients suffering from acute respiratory distress syndrome (ARDS). The latest patent application covers devices and […]